Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics

RVNC POWR Grades

• Growth is the dimension where RVNC ranks best; there it ranks ahead of 59.11% of US stocks.
• The strongest trend for RVNC is in Growth, which has been heading down over the past 177 days.
• RVNC ranks lowest in Stability; there it ranks in the 3rd percentile.

RVNC Stock Summary

• With a price/sales ratio of 25.67, REVANCE THERAPEUTICS INC has a higher such ratio than 94.8% of stocks in our set.
• RVNC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 91.31% of US stocks.
• Revenue growth over the past 12 months for REVANCE THERAPEUTICS INC comes in at 72.42%, a number that bests 88.23% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to REVANCE THERAPEUTICS INC are NTRA, LNSR, OCX, VMEO, and DMRC.
• RVNC's SEC filings can be seen here. And to visit REVANCE THERAPEUTICS INC's official web site, go to www.revance.com.

RVNC Valuation Summary

• In comparison to the median Healthcare stock, RVNC's price/sales ratio is 370.59% higher, now standing at 24.
• RVNC's price/sales ratio has moved down 710.5 over the prior 109 months.

Below are key valuation metrics over time for RVNC.

RVNC Growth Metrics

Its 4 year net cashflow from operations growth rate is now at -111.26%.
• Its 3 year revenue growth rate is now at 2254.05%.
• The year over year net cashflow from operations growth rate now stands at 0.91%.

RVNC's revenue has moved up $108,294,000 over the prior 67 months.

The table below shows RVNC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	108.594	-207.977	-273.568
2022-06-30	99.324	-203.273	-263.251
2022-03-31	89.76	-208.053	-274.013
2021-12-31	77.798	-221.538	-281.31
2021-09-30	62.981	-239.241	-296.521
2021-06-30	47.071	-241.76	-303.402

RVNC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RVNC has a Quality Grade of D, ranking ahead of 5.83% of graded US stocks.
• RVNC's asset turnover comes in at 0.068 -- ranking 297th of 681 Pharmaceutical Products stocks.
• HGEN, ZSAN, and ARMP are the stocks whose asset turnover ratios are most correlated with RVNC.

The table below shows RVNC's key quality metrics over time.